Quisinostat (JNJ-26481585) is a novel second-generation HDACi inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM, modest potent to HDACs 2, 4, 10, and 11; greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7. , in NSCLC cells. In vitro, quisinostat has shown anti-proliferative activity against NSCLC cell lines. quisinostat extremely changed protein acetylation patterns of A549 cells and inhibited epithelial-mesenchymal transition (EMT) process.
MoreApicidin是活性的HDAC (histone deacetylase) 抑制剂。
MoreUF 010是Class I HDAC 抑制剂。
MoreTCS HDAC6 20b是选择性 HDAC6 抑制剂。
MoreTC-H 106是Class I histone deacetylase(HDAC) 抑制剂。
MoreQuisinostat (JNJ-26481585) is a novel second-generation HDACi inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM, modest potent to HDACs 2, 4, 10, and 11; greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7. , in NSCLC cells. In vitro, quisinostat has shown anti-proliferative activity against NSCLC cell lines. quisinostat extremely changed protein acetylation patterns of A549 cells and inhibited epithelial-mesenchymal transition (EMT) process.
MoreApicidin是活性的HDAC (histone deacetylase) 抑制剂。
MoreUF 010是Class I HDAC 抑制剂。
MoreTCS HDAC6 20b是选择性 HDAC6 抑制剂。
MoreTC-H 106是Class I histone deacetylase(HDAC) 抑制剂。
MoreQuisinostat (JNJ-26481585) is a novel second-generation HDACi inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM, modest potent to HDACs 2, 4, 10, and 11; greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7. , in NSCLC cells. In vitro, quisinostat has shown anti-proliferative activity against NSCLC cell lines. quisinostat extremely changed protein acetylation patterns of A549 cells and inhibited epithelial-mesenchymal transition (EMT) process.
MoreApicidin是活性的HDAC (histone deacetylase) 抑制剂。
MoreUF 010是Class I HDAC 抑制剂。
MoreTCS HDAC6 20b是选择性 HDAC6 抑制剂。
MoreTC-H 106是Class I histone deacetylase(HDAC) 抑制剂。
MoreQuisinostat (JNJ-26481585) is a novel second-generation HDACi inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM, modest potent to HDACs 2, 4, 10, and 11; greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7. , in NSCLC cells. In vitro, quisinostat has shown anti-proliferative activity against NSCLC cell lines. quisinostat extremely changed protein acetylation patterns of A549 cells and inhibited epithelial-mesenchymal transition (EMT) process.
MoreApicidin是活性的HDAC (histone deacetylase) 抑制剂。
MoreUF 010是Class I HDAC 抑制剂。
MoreTCS HDAC6 20b是选择性 HDAC6 抑制剂。
MoreTC-H 106是Class I histone deacetylase(HDAC) 抑制剂。
More